A pivotal question in neuropharmacology is how the function of neurotransmitter systems relates to psychiatric diseases. In experimental neuropharmacology, we have dreamt about a looking glass that would allow us to see neurotransmitter systems in action, and about animals that would faithfully serve us as models for human psychiatric disease. Analysis of animal models has been limited by the availability of methods to study in vivo neurotransmitter dynamics. Now, a single photon emission computed tomography system called U-SPECT can localize dopamine transporters in sub-compartments of the mouse brain during a range of points in time. Applied to the midbrain dopamine system of different models of disease, this will aid the understanding of dynamic processes of this neurotransmitter that underlie brain functions and human brain pathology.
Functional imaging techniques, such as positron emission tomography (PET) and single photon emission computed tomography (SPECT), have revolutionized human neuropharmacology in the 1990s. They allowed us to experience part of our dream to see neurotransmitter systems in action in the living brain and emerged as important means to study aspects of neurotransmission systems in vivo, such as transporter and receptor densities (for a review see Booij et al.
1
). For the dopamine system, the imaging of the dopamine transporter (DAT) has become increasingly important since the DAT is subject to extensive modulation as a consequence of degenerating dopaminergic neurons in Parkinson's disease, and as the primary target of drugs of abuse, such as cocaine. 2, 3 Its function, the re-uptake of dopamine from the synaptic cleft, is crucial in the damping of dopaminergic transmission in the striatum, essential for movement control, attention and mood state. Since the DAT is implicated in neurological and psychiatric diseases of the central nervous system, Parkinson's disease, Alzheimer's disease, attention deficit hyperactivity disorder (ADHD), schizophrenia, Tourettes syndrome, obesity and depression, 4 it has become a major target for development of new pharmacotherapies. In line with this, the properties of DAT imaging have provided a window to the brain. Initially, PET and SPECT have proven their relevance in DAT imaging in preclinical and clinical Parkinson's disease, [5] [6] [7] [8] [9] providing the means to use these techniques as specific diagnostic tools. The development of new therapies and diagnostic tools rely heavily on the development and analysis of animal models. In this respect, dedicated PET and SPECT systems that enable imaging of the dopamine system in small laboratory animals are essential assets. Although these systems have shown the feasibility to detect DAT in rats and mice, [10] [11] [12] these systems lack the spatial and temporal resolution to study fast dynamic aspects of DAT occupancy as a measure of the state of dopaminergic tonus and release parameters in anatomical subdivisions of the forebrain.
We developed recently an ultra-high resolution pinhole SPECT system (U-SPECT-I), 13 which enables rapid dynamic and sub-millimeter resolution imaging in rodents. Most animal SPECT systems use one, up to a couple independent pinhole detectors that can acquire only a subset of the projections at the time, whereas heavy SPECT detectors need to be rotated several times to acquire projections under a sufficient number of angles. Stationary pinhole approaches were reviewed.
14 U-SPECT-I has stationary detectors and utilizes a cylindrical tungsten collimator in which 69 gold pinhole apertures are mounted that all focus on a small volume in the animal to maximize the detection yield of g-quanta emitted from the brain. From the 69 simultaneously acquired projections, three-dimensional SPECT images are reconstructed using the Maximum Likelihood Expectation Maximization (ML-EM) algorithm. 15 Recovery of resolution losses due to the finite pinhole size and g-camera blurring is performed by accurately modeling these effects during ML-EM reconstruction. 13 With 0.6-mm pinhole apertures, a resolution of less than 0.5 mm can be obtained, whereas a resolution of 0.35 mm have been reached with smaller pinholes.
14 Rapid temporal processes can be imaged, as effectively the pinhole cameras surround the animal while simultaneously observing the mouse brain. Here, we demonstrate that with the U-SPECT-I system DAT imaging is possible with a sub-millimeter resolution and subminute time frames in the mouse brain, allowing imaging of the immediate action of an addictive drug.
To analyze in vivo DAT occupancy in a dynamic context in the mouse, 140 MBq [ 16 a DAT radioligand, was injected intraperitoneally in male C57BL/6J mice (body weight approximately 30 g). SPECT projection data acquisitions of 45 s each were obtained, starting approximately 3 h and 40 min postinjection. Cocaine (30 mg/kg) was administered intraperitonealy 4 h after injecting FP-CIT. From the reconstructed three-dimensional SPECT images, movies of DAT-ligand (radioactivity) displacement in the striatum and associated regional time activity curves were generated from 17 min before the administration of the cocaine, up to 28 min after administration. The movie (available on-line at www.isi.uu.nl/People/Freek/) of which snapshots are presented in Figure 1 , shows tracer concentrations in fixed volumes of interest, positioned over the striatum bilaterally. From 17 min before administration of the cocaine up to 3 min after its administration, the striatal [ 123 I]FP-CIT concentration was stable. Thereafter it rapidly declined, with about 50% loss of DAT binding at 28 min after cocaine injection.
To demonstrate the feasibility of resolving DAT ligand binding in very small volumes, down to subcompartments of the brain, we performed a long SPECT acquisition (40 min, Figure 2a and c) . In this case, 38 MBq FP-CIT was injected in a male mouse (C57BL/6J, 30 g). A special data acquisition mode combined with an adapted ML-EM reconstruction algorithm 17 was used, which shifts the animal through the pinhole focus by a couple of millimeters per step during scanning to cover a larger area in the animal. Validation of the accuracy of the DAT binding obtained with this SPECT procedure was performed using autoradiography which was derived and adjusted from. 18, 19 Briefly, the coronal sections (16 mM) were pre-incubated in 50 mM Tris-HCl 120 mM NaCl (pH 7.5) for 20 min. Incubation was performed in 50 mM Tris-HCl 120 mM NaCl (pH 7.5) containing 50 pM [
125 I]RTI-55 and 1 mM Citalopram (a selective serotonin transporter re-uptake inhibitor) and Nisoxetine (selective norepinephrine transporter blocker) (400 ml) for 60 min. To determine the non-specific binding, control sections were incubated with the addition of 1 mM of GBR12909 (selective DAT blocker). Slides were rinsed twice for 10 s at 41C with the incubation buffer in containers. After that they were dipped rapidly in de-ionized water, dried under airflow and imaged using a phosphor imager (Bas 5000, Fuji-Film).
On the SPECT images shown in Figure 2a and c, different sub-striatal structures can be distinguished from each other, as the caudate putamen, nucleus accumbens and olfactory tubercle. The similarity between the SPECT image and the autoradiogram (Figure 2b and d) validates the accuracy to image DAT in the sub-millimeter range using this new focusing pinhole SPECT technique. This technique opens possibilities to distinguish different modes of action in dopamine transmission in relation to central nervous system (CNS) disease and (new) pharmacotherapies, which in a later stage can be used in human CNS pathology. Moreover, the dynamic process of occupancy of transporters, such as DAT or receptors, influenced by endogenous neurotransmitter release or peripheral administrated drugs (of abuse) can be visualized, and therefore used to gain a better understanding of how and why specific pharmacotherapy works to alleviate symptoms in, for example, ADHD and schizophrenia. This adds to the possibilities of analysis of specific disease processes in terms of dopaminergic-transmission dynamics. Moreover, the ability to monitor in vivo fast changes in the expression of DAT may be crucial to understand better the temporal coordination of this transporter in vivo. Owing to its high temporal and spatial resolution, this highly focusing pinhole SPECT technique offers the unique opportunity to characterize new SPECT tracers for potentially all kinds of receptors, which will be of importance for future research on neuropsychiatric diseases. Taken together, neuroreceptor imaging in vivo with a new technique which offers not only a high spatial resolution but also a high temporal resolution may not only improve our understanding of the pathophysiology of neuropsychiatric diseases, but it may be also of value to evaluate new potential diagnostic tracers and to monitor new therapeutic treatments, which in the end will improve our knowledge of neuropsychiatric diseases in humans. 
